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Abstract
Toll-like Receptor 3 (TLR3) detects double-stranded (ds) RNAs to activate innate immune responses. While poly(I:C) is an
excellent agonist for TLR3 in several cell lines and in human peripheral blood mononuclear cells, viral dsRNAs tend to be
poor agonists, leading to the hypothesis that additional factor(s) are likely required to allow TLR3 to respond to viral dsRNAs.
TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic
kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance
TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. The
polymerase from the genotype 2a JFH-1 HCV was a poor enhancer of TLR3 signaling until it was mutated to favor a
conformation that could bind better to a partially duplexed RNA. The 1b polymerase also co-localizes with TLR3 in
endosomes. RNA-binding capsid proteins (CPs) from two positive-strand RNA viruses and the hepadenavirus hepatitis B
virus (HBV) were also potent enhancers of TLR3 signaling by poly(I:C) or viral dsRNAs. A truncated version of the HBV CP that
lacked an arginine-rich RNA-binding domain was unable to enhance TLR3 signaling. These results demonstrate that several
viral RNA-binding proteins can enhance the dsRNA-dependent innate immune response initiated by TLR3.
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Introduction
Viral nucleic acids are agonists for innate receptors that can
activate anti-viral responses [1,2,3,4]. The receptors include the
RIG-I-like receptors that are localized to the cell cytoplasm and
several membrane-associated Toll-like receptors [5,6]. Mutations
in these receptors have been correlated with pathologies in viral
infections in humans [7,8,9,10]. Understanding how the innate
immune receptors can interact with agonists will be important for
the detection and response to viral infections.
Toll-like Receptor 3 (TLR3), the focus of this study, is composed
of a large ligand-binding ectodomain, a transmembrane helix, and
a signaling Toll/IL-1 receptor homology (TIR) domain [11,12].
The ectodomain contains 23 leucine-rich repeats flanked with
cysteine-rich caps and a bipartite motif, both of which are critical
for ligand binding [13,14]. TLR3 localizes to either the plasma
membrane or acidic endosomes, the latter was presumed to be the
site of high affinity binding to dsRNA [15,16]. Ligand binding
induces the TLR3 dimer to orient the two TIR domains to recruit
adaptor proteins and activate signal transduction [6,14].
Karioko et al. [17] have observed the activation of TLR3
signaling in cultured cells with complex ligand mixtures, such as
nucleic acids fractions from necrotic cells. However, we have
anecdotally observed that highly purified RNAs, including
necrotic RNAs, are poor activators of TLR3 in cultured cells
when compared to the synthetic dsRNA analog, poly(I:C). These
observations suggest that intrinsic features within dsRNAs can
influence signaling by TLR3. Also, component(s) in addition to the
dsRNAs are needed to activate TLR3. The antimicrobial peptide
LL37 and other peptides that can bind dsRNA were recently
found to enhance the TLR3 response to poly(I:C) and viral
dsRNAs [18]. Since viral RNAs exist as complexes with proteins,
we wanted to determine whether viral proteins could act to
modulate TLR3 signaling.
In this work, we determined that viral dsRNA-binding proteins
could substitute for LL37 in activating signaling by TLR3.
Furthermore, the proteins promoted more efficient recognition
of viral dsRNAs. The recombinant polymerases from the Hepatitis
C virus (HCV) and three viral capsid proteins were characterized
in this study.
HCV, a member of the Hepacivirus genus in the Flaviviridae
family, infects approximately 2% of the world’s population, with
up to 80% of untreated individuals progressing to chronic
infection and severe liver damage [19,20]. The HCV-encoded
polymerase, NS5B, is a validated drug target and has been
extensively characterized [21]. As with polymerases in general,
NS5B resembles a closed right hand that contains thumb, palm
and finger subdomains [19]. In vitro, recombinant NS5B proteins
can bind and initiate RNA synthesis by a de novo initiated
mechanism or by extension from a template annealed to a primer
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25837[22,23,24,25,26,27,28]. De novo initiated RNA synthesis uses a
single-stranded (ss) RNA template and a purine nucleotide as the
first nucleotide, while primer extension uses a partially duplexed
RNA [28]. The de novo initiated versus primer-extended modes of
RNA synthesis is regulated by a flexible loop named D1 that
extends from the fingers subdomain to contact hydrophobic
residues in the thumb subdomain [27]. The release of the D1 loop
is needed to sterically accommodate the ternary complex during
elongative synthesis. The polymerase from the 2a genotype of
HCV exists in a structurally more closed conformation than that of
the 1b polymerase in part due to a tighter contact between the D1
loop and the thumb subdomain [27,29,30]. This feature has been
proposed to allow the 2a polymerase to be more efficient at RNA
synthesis by the de novo initiated mechanism since it cannot initially
accommodate a partially duplexed RNA.
Two of the viral capsid proteins we examined are from
members of the alphavirus-like superfamily with positive-stranded
RNA genomes: Ross River virus (RRV) and Brome mosaic virus
(BMV) [31,32]. The third is from the orthohepadnavirus,
Hepatitis B virus (HBV), which has a partially dsDNA genome
and replicates by reverse transcription [33,34]. The capsids of all
three viruses contain a positively-charged arginine-rich region that
is required for RNA binding [35,36,37,38,39].
Results
Viral dsRNAs are poor agonists for TLR3
We have anecdotally observed that cultured cell lines that
express TLR3 respond poorly to viral dsRNAs when compared to
the response to poly(I:C). To document this observation, BEAS-2B
cells that endogenously express TLR3, TLR4, and RIG-I were
examined for their response to several dsRNAs. BEAS-2B cells
have been used extensively to study the effects of viral infection
and activation of innate immunity on cytokine production,
including the production of Interleukin 6 (IL6) [40,41,42]. The
dsRNAs tested include the Reovirus genomic RNA, the S4
dsRNA made by annealing in vitro transcribed positive- and
negative-sense strands of the Reovirus S4 RNA, and the Bell
pepper endornavirus dsRNA, BPEV, purified from bell pepper
plants [43], and other viral and synthetic dsRNAs. Transcripts of
the JFH-1 genome were used as a ssRNA control. All the RNAs
were added to the media of BEAS-2B cells and the amount of
cytokine IL6 secreted into the medium quantified by ELISA
(Fig. 1A). At 20 h, IL6 levels induced by poly(I:C) (0.13 mg/ml)
was at least six-fold higher than that of dsRNAs or ssRNA (0.3 mg/
ml; Fig. 1A and Fig. S1A). The production of IL6 in response to
poly(I:C) was rapid and could be observed within 2 h of poly(I:C)
addition (Fig. S1B). In contrast, cells treated with S4 dsRNA did
not yield level of IL6 significantly above the background even after
20 h (Fig. S1B).
HEK 293T cells do not detectably express TLR3 but can be
transfected to express either wild-type or mutant TLR3 [44].
Transfection of two plasmids, one containing an interferon
stimulated response element (ISRE) promoter-driven firefly
luciferase and a second encoding a constitutively expressed Renilla
luciferase allow the analysis of TLR3 activation by different RNAs.
HEK 293T cells expressing WT TLR3 responded to poly(I:C) (1–
2 mg/ml), better than viral dsRNAs (1–2 mg/ml) purified from
Reovirus and BPEV (Fig. 1B). Annealed S4 Reovirus dsRNA,
ssRNAs from JFH-1 (Fig. 1B), endornavirus dsRNA from rice
plants and other viral ssRNAs (Fig. S1C) also had no effect on
TLR3 signaling. None of RNA tested induced reporter activity in
HEK 293T cells expressing a TLR3 mutant H539E that had a
substitution at the C-terminal ligand-binding domain [16,45]
(Fig. 1B) or in cells transfected with the empty vector (data not
shown), demonstrating that the observed responses are from
TLR3. The results from 293T cells are consistent with those from
the BEAS-2B cells and support our observation that viral dsRNAs
are poor agonists in comparison to poly(I:C).
To determine whether TLR3 was responsible for the increased
IL6 levels, we treated cells with siRNAs specific to TLR3, RIG-I,
or a nonspecific control for 48 h prior to the addition of BPEV
dsRNA to the cells (Fig. 1C). RIG-I is a suitable control in this
experiment since it also recognizes dsRNA [46]. Only cells treated
with siRNAs to TLR3 had reduced IL6 levels in the presence of
BPEV dsRNA (Fig. 1C). With poly(I:C)-induced cells, siRNAs to
TLR3 also reduced IL6 production by 5163% (n=4) (data not
shown; [18]). RT-PCR confirmed that the siRNAs did knock
down TLR3 mRNA levels in both untreated and poly(I:C) treated
cells (Fig. 1D). ODN2006, which we previously shown to inhibit
TLR3 signaling [47] reduced the IL6 levels in the presence of
poly(I:C) to less than 20% of the control reaction (data not shown)
while EGCG, an inhibitor of RIG-I [48] had no effect on IL-6
production in the presence of poly(I:C) (data not shown). Thus,
while the viral dsRNAs are poor TLR3 agonists, the low level of
cytokine production by BEAS-2B cells was primarily due to the
activation of TLR3. These results form the basis of the hypothesis
to be tested in this work: the activation of TLR3 by viral dsRNA
requires additional factors.
Several viral dsRNA-binding proteins can enhance
poly(I:C)-dependent signaling
Addition of the peptide LL37 to the cell culture media along
with poly(I:C) or viral dsRNAs was found to enhance signaling by
TLR3 [18]. LL37 binding to the dsRNA was correlated with
enhancement of TLR3 signaling [18]. Since RNAs in cells exist in
complex with proteins, we postulate that viral RNA-binding
proteins could also enhance the TLR3 response to the viral
dsRNAs. Several highly purified RNA-binding proteins were
selected to test this idea. These include the recombinant Nsp15
protein from the SARS coronavirus that binds ssRNAs [49], two
versions of the Hepatitis B virus capsid protein (H-cp149 and H-
cp183) [38], the capsid protein from the Ross River virus (R-cp)
[39], the capsid from the plant-infecting Brome mosaic virus (B-cp)
[50] and polymerases from the 1b and 2a genotypes of the
Hepatitis C virus (1bD21 and 2aD21) [27]. Except for the B-cp,
which was extracted from cesium-chloride purified BMV virions,
the other proteins were produced in E. coli.
While the cytokine induction by the various RNA-binding
proteins in the absence of poly(I:C) varied depending on individual
experiments, fold inductions of IL6 above basal across multiple
experiments showed no statistically significance in paired T-tests
(Fig. 2 and Table S1). These results, including those from B-cp
that was produced in plants also suggest that common contam-
inants such as lipopolysaccharides which would induce TLR4
signaling, is not a significant factor in the assays. Incubation of
poly(I:C) with the corresponding buffers in which the proteins
were purified also did not result in a significant change of cytokine
production (data not shown). The presence of poly(I:C) (0.13 mg/
ml) alone induced IL6 and IL8 levels at least five-fold above
background (Fig. 2). Several of the proteins added to a final
concentration of 0.15 mM along with poly(I:C) resulted in
additional increases in IL6 and IL8 levels of two- to five-fold
(Fig. 2A and 2B; Table S1). The level of enhancement by the
recombinant proteins were comparable to that observed with
LL37 (3 mM).
The viral proteins that did not significantly increase cytokine
production include the polymerase from HCV genotype 2a
Viral Proteins Enhance TLR3 Signaling
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25837Figure 1. A comparison of viral dsRNAs and poly(I:C) for activation of TLR3. A) Effects of various potential TLR3 ligands on IL6 production
by BEAS-2B cells. All of the RNAs were added to the culture media. Poly(I:C) (pIC) was added to 0.13 mg/ml and the other RNAs were added at 0.13 to
0.3 mg/ml. IL6 was quantified in an aliquot of clarified cell medium, and the total amount of IL6 was normalized to the total medium volume. The data
shown is the mean 6 SEM, with the number of assays in parentheses: pIC (n=23), Reovirus dsRNA (ReoV, n=9), Reovirus S4 dsRNA (S4; n=28), BPEV
(n=6), JFH1 (n=3). B) A comparison of the effects of viral dsRNAs and poly(I:C) in HEK 293T cells transfected to express the WT TLR3 or a ligand-
binding mutant, H539E. Activation of TLR3 was measured by the ratio of the firefly luciferase driven by an ISRE promoter element to a constitutively-
expressed Renilla luciferase [47]. Each bar represents the mean value of three replicates, with the range for one standard error shown above the bars.
C) TLR3 is required for the increase in IL6 production in response to BPEV dsRNA. BEAS2B cells were transfected with a control nonspecific siRNA
(nsRNA), a set of three siRNAs to TLR3 (siTLR3), or a siRNA to RIG-I (siRIG-I), grown for 48 h before addition of BPEV dsRNA (0.3 mg/ml) to the culture
media. D) RT-PCR results demonstrating that the siRNA targeting TLR3 decreased the abundance of the TLR3 message. BEAS2B cells were transfected
with either control nonspecific siRNA or siRNAs to TLR3. After 48 h, cells were exposed to media alone (f) or to poly(I:C) at 0.13 mg/ml. RT-PCR was
performed to determine fold induction of TLR3 mRNA above media 18 h later. Data is presented as a percent of the result from the nonspecific siRNA.
doi:10.1371/journal.pone.0025837.g001
Figure 2. Several recombinant proteins can enhance cytokine production by poly(I:C). A) Quantification of IL6 production by BEAS-2B
cells in response to the presence of various viral proteins with or without poly(I:C) at a final concentration of 0.13 mg/ml. Each protein was present at
a final concentration of 0.15 mM. The antimicrobial peptide LL37 was added to 3 mM final concentration. IL6 was quantified in an aliquot of clarified
cell medium and the total amount of IL6 was normalized to the total medium volume. The standard errors were from at least three replicates. B) A
representative analysis of IL8 production by BEAS-2B cells in response to the exogenously added proteins. The conditions for the assay are identical
to those in panel A.
doi:10.1371/journal.pone.0025837.g002
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Nsp15 (Fig. 2A and 2B). The Nsp15 used in this experiment is a
catalytic-inactive version of an endoribonuclease that binds and
preferentially cleaves ssRNAs [49]. Identical results were obtained
with the WT Nsp15, hence the enzymatic activity of Nsp15 is not
a factor in the response (data not shown). These results show that a
subset of the RNA-binding proteins is more competent in
enhancing TLR3 signaling. The activities of the HCV polymerases
and the viral capsids will be analyzed in turn below.
The HCV 1b polymerase can enhance dsRNA-induced
signaling by TLR3
We seek to determine whether the observed IL6 production in the
presence of the 1b HCV polymerase was due to signaling by TLR3.
SiRNAs to TLR3, to RIG-I, or to a nonspecific target were
transfectedintoBEAS-2Bcellspriortotheadditionofeitherpoly(I:C)
alone or poly(I:C) and 1bD21 (Fig. 3A).Onlythe cellstransfected with
the siRNAs to TLR3 had reduced IL6 production compared to cells
transfected with nsRNA (Fig. 3A; p,0.05). We reproducibly
observed using RT-PCR that TLR3 mRNA treated with the siRNAs
were reduced to between 8 and 26% of the level in cells treated with
the nsRNA control (Table S2). The presence of the polymerase did
not change LPS-induced TLR4 response or change the response
from cells treated with only polyinosinic acid, suggesting specific
induction of TLR3 (Fig. 3B). Moreover, ODN2006, an inhibitor of
TLR3 signaling [47] reduced IL6 levels to 4067% of control while
EGCG, an inhibitor of RIG-I [48] had no effect, further suggesting
that the enhancement of dsRNA induced signaling is dependent on
TLR3 (data not shown). The HCV polymerase also enhanced the
response to poly(I:C) lengths that ranged from 45 to 125 bp (Fig.
S2A). These results indicate that TLR3 is required for 1bD21 and
poly(I:C) to enhance cytokine production.
1bD21 is less active for RNA synthesis in vitro than is the 2aD21
[27,29,30]. Therefore, it is unlikely that RNA synthesis by 1bD21
is responsible for the induction of TLR3 signaling. However, to
establish this directly, we tested a catalytic mutant named GDA
wherein the divalent metal-binding motif required for polymeri-
zation was mutated. We also tested three additional mutants that
are defective for de novo initiation, including a five-residue deletion
of the D1 loop name m26–30 [26]. The locations of the key
mutations in the 1b polymerase structure are shown in Fig. 3C.
Since m26–30 has a major change in conformational to 1bD21, we
tested it for the ability to bind a dsRNA of ca. 900 bp derived from
Reovirus genome and found that retained the ability to bind
dsRNA (Fig. 3D). All of these mutant polymerases enhanced IL6
production over the level of poly(I:C) alone by at least two-fold
(Fig. 3E and Fig. S2B).
Figure 3. The 1b HCV polymerase can enhance IL6 production by BEAS-2B cells. A) Enhanced IL6 production in the presence of 1bD21 can
be knocked down by SiRNA to TLR3. siRNAs specific to TLR3 (siTLR3), RIG-I (siRIG-I), or a nonspecific control (nsRNA) were transfected into at a
concentration of 30 nM into cells 48 h prior to the addition of 1bD21 (0.15 mM) and poly(I:C) (0.13 mg/ml) to the culture medium. IL6 in the medium
was collected 24 h later and quantified by ELISA. The data from 3 to 4 sets of samples are presented as a percentage of the IL6 in the sample treated
with nsRNA (100%). B) IL6 production by BEAS-2B cells in response to stimulation by the single-stranded polyinosinic acid (0.13 mg/ml), poly(I:C)
(0.13 mg/ml) or lipolysaccharide (LPS) (1 mg/ml), the agonist for TLR4 in the absence (Ø) or presence of 1bD21 (0.15 mM). C) A model of the 1b HCV
polymerase that illustrates the location of the D1 loop (in light blue), the GDD active site (in yellow), and the short helix deleted in mutant m26–30 (in
red). D) The 1bD21 polymerase and 1b.m26–30 can form a complex with the double-stranded S4 RNA. The S4 dsRNA was labeled with a-
32P-CTP and
used in an electrophoretic mobility shift assay. The gel image shown is from a non-denaturing stacked polyacrylamide gel of 5 and 20%. E) Effects of
mutations in 1bD21 on IL6 production induced by poly(I:C). f denotes a reaction with no added proteins. Proteins 1bD21, 1b.m26–30, and the active
site mutant GDA were added to the culture media (final concentrations 0.01, 0.1 or 0.5 mM) in the absence or presence of 0.13 mg/ml poly(I:C). LL37
was added to a final concentration of 3 mM. F) The 1b HCV polymerase (1bD21, 0.1 mM), but not the 2a polymerase (2aD21, 0.1 mM), allowed TLR3 to
produce cytokines in response to viral dsRNAs. In addition to poly(I:C), the RNA ligands used were those extracted from Reovirus virions (ReoV), from
the endornavirus BPEV, and the annealed transcripts of the sense and antisense strands made from the S4 cDNA of Reovirus (S4), and the transcript of
the HCV 2a JFH-1.
doi:10.1371/journal.pone.0025837.g003
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production in concert with viral RNAs (Fig. 3F). In the absence
of 1bD21, the single-stranded JFH-1 RNA and three different viral
dsRNAs were poor inducers of IL6 production in BEAS2B cells
when compared to poly(I:C). This result is consistent with our
initial observation that TLR3 does not respond efficiently to viral
RNAs (Fig. 1A & 3F, Fig. S1A). 1bD21 (0.1 mM) increased IL6
levels induced by the S4 dsRNA and the BPEV dsRNA by 4 to 6-
fold (Fig. 3F). 1bD21 had only a modest increase when JFH-1
ssRNA was used as a ligand. In contrast, the activation of signaling
was approximately 20-fold higher with dsRNA than with JFH-1
(Fig. 3F). Consistent with our previous observation, 2aD21
(0.1 mM) was unable to enhance IL6 production when added to
cells along with either the ssRNA or dsRNA (Fig. 3F).
The conformation of 2aD21 can affect dsRNA-dependent
TLR3 signaling
2aD21 differs from 1bD21 in the relative amounts of product
generated from de novo initiated RNA synthesis or extension from a
primed template (Fig. 4A). 2aD21 produced high levels of de novo
initiated RNA when compared to the primer extension products
while 1bD21 produced similar amounts of the two products
(Fig. 4A). In this assay, de novo initiated RNA synthesis was
determined with template LE19P, whose 39 terminal puromycin
prevents primer extension, while primer extension used template
PE46, which contains a partially double-stranded hairpin structure
that can be extended by the polymerase. The products of the two
modes of RNA synthesis demonstrate whether a single or a
partially duplexed RNAs are bound in the template channel of the
polymerase [24–26]. Furthermore, products from the two
templates are associated with two distinct polymerase conforma-
tions: a structurally closed conformation can initiate better by a de
novo mechanism or a more open conformation that favors primer
extension [26]. Notably, the crystal structure of 2aD21 has a more
closed conformation than that of 1bD21 due to additional
interactions between the D1 loop and the thumb subdomain of
the polymerase [29].
If the closed conformation of 2aD21 decreases its ability to bind
dsRNA and to induce TLR3, a five-residue deletion at the tip of
the D1 loop which results in a more open conformation should
Figure 4. A mutant HCV 2a polymerase can enhance TLR3 signaling. A) In vitro RNA synthesis by the 1bD21, the 2aD21 and the 2a mutant
2a.m26–30. The final concentrations of proteins were at 40, 80, and 160 nM. The templates used, LE19P and PE46, can, respectively, produce de novo
initiated products (DN) as well as those extended from a partial duplex RNA (labeled as ‘‘PE’’) as described in Chinnaswamy et al. [27]. B) The
denaturation profile of the proteins (5 mM) analyzed by differential scanning fluorimetry. The reactions were performed in a Stratagene Mx3005P real-
time PCR machine in the presence of SYPRO orange, which fluoresces when complexed to denatured proteins. The ramp for temperature increase
was at 0.5uC per min. C) The mutant HCV 2a polymerase, 2am26–30, can enhance poly(I:C) (0.13 mg/ml)-induced IL6 production by BEAS-2B cells. D)
The sequence and likely structure of a fluorescently-labeled RNA, SL26, used to analyze polymerase-dsRNA interaction. E) Binding of SL26 by the three
HCV polymerases. The proteins were mixed together with a 1:1 molar ratio of SL26 then crosslinked with a Stratalinker prior to analysis by SDS-PAGE.
The gel image on the left shows the fluorescently-labeled RNA shifted above the free SL26 at the bottom of the gel. The complexes that contain a
monomer or a dimer of the HCV polymerase are labeled to the left of the gel image. The same gel was then stained with Coomassie blue to allow
visualization of the proteins, the image of which is shown to the right.
doi:10.1371/journal.pone.0025837.g004
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primed template. A protein with such a deletion named 2a.m26–
30 was found to be debilitated in de novo initiated RNA synthesis
while retaining the ability to extend from a primed template
(Fig. 4A). 2a.m26–31 also showed a distinct thermal denaturation
profile compared to that of 2aD21, when analyzed by differential
scanning fluorimetry, consistent with the two proteins having
different conformation(s) (Fig. 4B). Protein 2a.m26–30 added to
BEAS-2B cells had no effect on IL6 production (Fig. 4C). When
added along with poly(I:C) to BEAS-2B cells, 2a.m26–30
dramatically enhanced IL6 production to levels comparable to
reactions containing 1bD21 (Fig. 4C, n=4). These results clearly
demonstrate that the conformations of the HCV polymerase that
impact interaction with single or double-stranded RNAs affect the
ability of the polymerase to enhance signaling by TLR3.
The deletion of the D1 loop in the 1b polymerase makes the
template channel more accessible to dsRNAs [27]. To determine
whether 2a.m26–30 was altered in RNA binding in comparison to
2aD21, we performed a UV-crosslinking assay with a fluores-
cently-labeled RNA SL26, which contains a GNRA tetraloop with
an 11-bp stem (Fig. 4D). The 26-nt SL26 was used to minimize
non-specific interaction by the polymerase so as to better analyze
RNA binding potential of polymerase mutant. The RNA-protein
complex was visualized with a phosphorimager and the position of
the protein identified by staining with Coomassie blue (Fig. 4E).
The purified HCV polymerase usually exists as a mixture of
monomers and higher order oligomers [27]. Both the monomeric
and dimeric forms of 2a.m26–30 bound SL26 better than those
from 2aD21 (Fig. 4E). Taken together, these results show that the
changes in 2a polymerase to increase its binding to a largely
dsRNA is correlates with increased enhancement of TLR3
signaling.
Cellular localization of 1bD21
We sought to determine whether the recombinant HCV
polymerase could enter cells and co-localize with TLR3 in
endosomes. 1bD21 added to the medium of BEAS-2B cells in
the absence of poly(I:C) was localized to punctate spots within
30 min. of addition (Fig. 5A). Some of these spots co-localized with
Lysotracker that stains acidic compartments in the cell where
TLR3 is located (Fig. 5B; [15]). The observation that not all of the
dsRNA co-localized with TLR3 is consistent with previous reports
that dsRNA could traffic into cells independent of TLR3 [47,51].
To determine whether 1bD21 co-localized with TLR3, cells
exposed to 1bD21 for 6 h were stained with the antibodies to
TLR3 and the HCV polymerase. Signals to both proteins
overlapped significantly, although not at every location where
TLR3 was detected (Fig. 5C). The co-localization of the HCV
polymerase to endosomes containing TLR3 may factor into the
mechanism to enhance TLR3 signaling.
The localization of 1bD21 in BEAS-2B cells suggests that it is
taken up by endocytosis. Arginine-rich cell penetrating peptides
and Vaccinia virus had been reported to enter cells by several
pathways, including macropinocytosis [52,53,54]. To examine
whether macropinocytosis is likely involved in the uptake of
1bD21, we tested the inhibitor 5(N-ethyl-N-isopropyl)-amiloride
(EIPA) on TLR3 signaling in the presence of poly(I:C) and either
LL37 or recombinant 1bD21 (Fig. S3). EIPA dose-dependently
inhibited TLR3 signaling by either poly(I:C) alone, or poly(I:C)
added to the cell culture medium along with LL37 or 1bD21.
These results are consistent with macropinocytosis playing a role
in the uptake of either the dsRNA and/or the recombinant protein
into endosomes.
Capsid proteins and TLR3 signaling
To extend the analysis of viral protein-RNA interaction further,
we characterized the effects of three capsid proteins (CPs) that
enhanced the dsRNA-specific innate immune signaling (Fig. 2).
Knockdowns of TLR3, RIG-I, or a nonspecific target prior to
stimulation with poly(I:C) and the CPs (50 nM) showed that TLR3
was the receptor primarily responsible for IL6 production for H-
cp184 and R-cp (Fig. 6A). SiRNAs to TLR3 also decreased B-cp
induced IL6 production (data not shown). In addition, all three
WT viral CPs increased IL6 production in a concentration-
dependent manner (Fig. S4). H-cp149 that lacks the C-terminal
sequence of H-cp183 (Fig. S4A) was unable to modulate IL6
production (Fig. S4B).
We examined whether the CP can enhance signaling by viral
ssRNA or dsRNA. IL6 level were enhanced when the Reovirus
genomic RNAs and the S4 dsRNA (all at 0.15 mg/ml) were added
to the medium in the presence of H-cp183. The single-stranded
JFH-1 RNA was not significantly enhanced by H-cp183.
Furthermore, H-cp149 did not result in statistically significant
enhancement of IL6 in the presence of viral dsRNAs or the JFH1
ssRNA (Fig. 6B, Fig. S4B). The amount of enhancement with the
150 nM of H-cp183 was comparable to that of 3 mM LL37. The
Figure 5. The HCV polymerase 1bD21 co-localizes with TLR3 in
endosomes. A) Location of 1bD21 in BEAS-2B cells. 1bD21 (0.2 mM)
was added to the medium of cells for 1 h and then detected by a mAb
from Alexis Biochemicals. The locations of 1bD21 were then superim-
posed on a brightfield image of the same cells. B) NS5B is localized to
acidic compartments in cells. BEAS-2B cells were stained with
Lysotracker (Invitrogen, Inc). Lysotracker is colored red and sites of
overlap between 1bD21 and lysotracker are in yellow. C) 1bD21 co-
localizes with TLR3. A confocal section of a cell immunostained to
localize both TLR3 and 1bD21, as well as the comparable brightfield are
shown in the merged image. The yellow color identifies positions where
the TLR3 and 1bD21 co-localized.
doi:10.1371/journal.pone.0025837.g005
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both poly(I:C) as well as viral dsRNAs.
RNA-binding is required to enhance dsRNA-dependent
signaling by TLR3
The differential effects of H-cp183 and H-cp149 should reveal a
requirement important for the enhancement of dsRNA-dependent
signaling by TLR3. The HBV CP contains sixteen arginines in its
C-terminal thirty-four residues (Fig. S4A). H-cp149 is competent
for the formation of virus-like particles, but is defective for binding
to RNA [38]. It is therefore likely that the altered interaction with
RNA is responsible for the inability of H-cp149 to enhance TLR3
signaling when compared to the other capsid proteins. Again, to
reduce the effects of nonspecific RNA binding inherent to many
RNA-binding proteins, SL26 containing an 11-bp dsRNA was
used to examine whether H-cp183 and H-cp149 are distinguish-
able in their ability to bind RNA. SL26 bound H-cp183 as well as
B-cp, and the R-cp (indicated by shifts to higher molecular mass
smears). However, no shift occurred with H-cp149 (Fig. 6C).
These results provide another set of example wherein a viral
protein’s ability to bind dsRNA is linked to the enhancement of
TLR3-dependent signaling.
The RRV CP can enter cells and co-localize with TLR3 in
endosomes
The HCV polymerase 1bD21 co-localized with TLR3 in
endosomes (Fig. 5). The BMV CP has also been shown to enter
barley cells through macropinocytosis and localize to punctate
spots within the cytoplasm that are suggestive of endosomes [53].
The HBV capsid can also enter cells, although permeabilization of
the cells with digitonin was required [55]. We seek to determine
whether the capsid proteins can localize to endosomes that contain
TLR3, using the R-cp as an example. 2 h after the addition of R-
cp to the media of BEAS-2B cells, R-cp was found close to the
plasma membrane, with a small proportion of the signal localizing
in endosomes (Fig. S5). At 6 h after R-cp addition, the majority of
the signal was within endosomes (Fig. 7). Immunostaining to detect
TLR3 revealed an extensive co-localization of R-cp (Fig. 7).
RNA-binding proteins can enhance viral dsRNA-
dependent signaling in HEK 293T cells
The effects of the HCV polymerases and the viral capsid
proteins have thus far been examined in BEAS-2B cells. We seek
to determine whether they could enhance signaling in HEK
293T cells transiently transfected to express TLR3. TLR3-
specific activation of luciferase production from an ISRE
promoter element was used to assess signal transduction.
Reporter production in the presence of poly(I:C), and Reovirus
genomic dsRNA were all reproducibly enhanced in the presence
of 1bD21 or 2a.m26–30, but not with 2aD21 (Fig. 8A). As with
the BEAS-2B cells, JFH1 RNA was unable to induce TLR3 in
HEK 293T cells. The activation of reporter production was
dependent on the concentration of 1bD21 added to the 293T cell
culture media (Fig. 8B). The effects of the viral CPs on TLR3
signaling in HEK cells were also examined using the Reovirus
dsRNA as the TLR3 ligand. B-cp, H-cp183, and the R-cp all
Figure 6. Effects of three viral capsids on IL6 production by BEAS-2B cells. A) Enhancement of IL6 production by the viral capsids requires
TLR3. SiRNAs to TLR3, siRNA to RIG-I, or a nonspecific target were transfected at 30 nM into the cells 48 h prior to the addition of the viral capsid
proteins (50 nM) either alone or in combination with poly(I:C) (0.13 mg/ml). B) Effects of H-cp183 or H-cp149 (50 nM) and viral dsRNAs on the
production of IL6. The reactions with LL37 serve as a positive control. DsRNA S4 is a mimic of the shortest of the Reovirus dsRNAs (ca. 1100 bp) made
by annealing in vitro transcripts of the plus- and minus-sense RNAs. RV denotes the total virion RNA purified from reovirus particles. JFH-1 is the in
vitro transcript of the genotype 2a HCV. C) Effects of increasing B-cp, R-cp, H-cp183, and H-cp149 on the ability to bind and crosslink to SL26. The
crosslinking reactions were electrophoresed on SDS-PAGE and imaged on a Phosphorimager.
doi:10.1371/journal.pone.0025837.g006
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when compared to cells transfected with only the empty plasmid
vector (Fig. 8C). This result shows that all five recombinant
proteins that enhanced TLR3 signaling with viral dsRNAs in
BEAS-2B cells enhanced TLR3-dependent signaling in HEK
293T cells.
Discussion
While TLR3 binds to dsRNA to activate innate immune
responses, viral dsRNAs tend to be poor TLR3 agonists, especially
when compared to the synthetic dsRNA analog, poly(I:C). In a
companion manuscript [18], we demonstrated that LL37 is a
potent enhancer of dsRNA-dependent TLR3 signaling. Herein,
we demonstrate that a subset of viral proteins can significantly
enhance both poly(I:C) and viral dsRNA-induced TLR3 signaling.
These viral proteins include polymerases from two genotypes of
hepatitis C virus and three viral capsid proteins. Requirements for
the polymerases and capsid proteins (1bD21, 2a.m26–30, B-cp, R-
cp, and H-cp183) to activate TLR3 signaling were examined and a
common property is the ability to bind dsRNAs. Two proteins
(2aD21 and H-cp149) that bind dsRNA less well are also less
effective in enhancing TLR3 signaling. These results suggest that
features that affect dsRNA binding modulate the ability of proteins
to activate TLR3 signaling. A second requirement elucidated with
the 1b HCV polymerase and the RRV CP is the ability of the
proteins to enter cells and co-localize with TLR3 in endosomes.
The focus of the discussion below will be on the requirements for
activating TLR3 signaling, with a final section on the conforma-
tion of the HCV polymerase.
Agonists for TLR3
The chemical features in dsRNA that are recognized by TLR3
are poorly understood. The difference between what makes
poly(I:C) a good TLR3 agonist in the absence of RNA-binding
proteins and what makes the viral dsRNAs inferior ones will
require in-depth analysis. We believe that this work identifies
conditions that will facilitate these efforts. Based on our current
results, Reovirus S4 dsRNA made by in vitro transcription is as
potent a TLR3 agonist as the genomic dsRNA extracted from
Reovirus virions, suggesting that no obvious posttranscriptional
modifications are required to activate TLR3 signaling. Another
feature of poly(I:C) that may obviate the need for viral proteins or
LL37 may be that the inosine-cytosine base pair has only two H-
bonds. We observed that poly(A:U) is also an excellent agonist for
TLR3 in the absence of LL37 and viral protein (Fig. S1A).
However, weaker base pairing alone is unlikely to provide the full
explanation for poly(I:C) being such a potent agonist; poly(G:U),
which also has two H-bonds per base pair, is a poor agonist for
TLR3 signaling in the absence of viral dsRNA proteins (Fig. S1A).
We can offer the following observations on proteins and
peptides that can enhance TLR3 signaling. The proteins can be
produced in E. coli or extracted from virions (as in the case of
BMV), suggesting that post-translational modifications are not
required for the enhancement of the TLR3 response. Similarly,
peptides such as LL37 that are potent enhancers of TLR3
signaling can be synthesized chemically without specific modifi-
cations [18]. In addition, both enzymes and structural proteins can
be potent enhancers of TLR3 signaling as long as they interact
with either dsRNA or partially duplexed RNAs. The SARS-CoV
Figure 7. The RRV CP can enter cells and co-localize with TLR3. A) A merged brightfield image of BEAS-2B cells and the locations of the R-cp.
The R-cp was added to the cells for 2 h prior to processing the cells for immunolocalization. R-cp antibody was custom made by Cocalico Biologicals
(Reamstown, PA). The boxed area in the upper right corner is increased in size in the lower figure to allow better visualization of the punctate spots of
R-cp within the cell. Co-localization of the R-cp with TLR3 is shown in the magnified images. TLR3 is imaged in blue and R-cp in red and locations of
co-localization in yellow.
doi:10.1371/journal.pone.0025837.g007
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not efficiently enhance TLR3 signaling. A deletion that increased
interaction between the 2a HCV polymerase and a partially
duplexed RNA template made the polymerase a better enhancer
for TLR3 signaling (Fig. 4C). The second feature of the TLR3
enhancers is that they have the ability to form oligomers. This is
intuitive with the viral capsid proteins, but viral RdRps have
surfaces that mediate oligomerization that may facilitate RNA
binding [56,57,58]. Indeed, oligomerization of the HCV poly-
merase can affect the mode of RNA synthesis [27]. LL37 also
exists in higher order complexes in the absence of RNA and is
required at micromolar concentrations in contrast to the viral
proteins that are active in our assays at nanomolar concentrations.
This is likely due to multiple LL37 molecules being needed to bind
and/or coat the dsRNAs and mediate TLR3 activation [18].
The fact that BMV and RRV encapsidate ssRNAs may initially
seem to incompatible with their ability to enhance signaling by
dsRNAs. However, the encapsidated viral RNAs are highly
compacted and contain a high percentage of dsRNAs with non-
Watson-Crick base pairing, close to 70% [59,60]. This likely
explains how the CP can bind the dsRNA needed to activate
TLR3. The CP’s of BMV and RRV are capable of binding to the
double-stranded S4 RNA in an electrophoretic mobility shift assay
(Fig. S4C). In the context of a viral infection, however, we note it is
likely that fully assembled virions may not result in activation of
TLR3 signaling if the dsRNAs are not exposed. We have added
highly purified BMV virions and Reovirus virions to BEAS-2B
cells and 293T cells expressing TLR3 and have not observed
induction of cytokines or TLR3-specific reporters (Kao and
Ranjith-Kumar unpublished results).
We also demonstrated that two dsRNA-binding proteins that
can enhance TLR3 signaling can colocalize with TLR3 in
endosomes. Whether the dsRNA-binding proteins facilitate
binding of the dsRNA by the TLR3 or the uptake of dsRNA to
endosomes remain to be determined. However, it is known that
TLR3 binds to linear dsRNA [61]. TLR3, unlike the RIG-I-Iike
receptors [62], lacks helicase activity to unravel the tertiary
interactions that could stabilize the dsRNA. The dsRNA-binding
proteins could disrupt the tertiary structure in the dsRNAs to
facilitate recognition of the dsRNA by TLR3. Electron microscopy
revealed that LL37 decreases the particle size of the primarily
globular poly(I:C) and results in more filamentous structures [18].
With the second scenario, the dsRNA-binding proteins could
facilitate entry of the viral dsRNAs into endosomes, perhaps by
Figure 8. Viral proteins can enhance TLR3-dependent reporter expression in HEK 293T cells. A) The effects of HCV polymerases on ISRE-
luciferase expression in 293T cells transiently-transfected with TLR3. All recombinant proteins used were added to cell culture media to a final
concentration of 100 nM. The ratio of the firefly luciferase levels to the Renilla luciferase is shown on the Y-axis. B) The recombinant 1bD21 protein (0
to 150 nM) concentration-dependently increased the ratio of the firefly to Renilla luciferases induced by RV dsRNA (1 mg/ml). C) Purified CPs can
enhance TLR3-dependent signaling from RV dsRNA in a concentration-dependent manner. The ratios are from ISRE-dependent firefly luciferase levels
over the Renilla luciferase. The concentrations of the CP used in the assay are shown on the horizontal axes. The mean values of at least three
independently assayed samples are shown above the bars.
doi:10.1371/journal.pone.0025837.g008
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scavenger receptors [51], but these RNA-binding proteins likely
need to complex and bring dsRNA to endosome in order for
TLR3 activation to occur. The net effect is an increase in the
concentration of ligand available to TLR3. Further studies will be
required to unravel the complex requirements whereby the
dsRNA-binding protein activate TLR3 signaling.
Our demonstration that LL37 and viral dsRNA-binding
proteins can enhance TLR3 signaling raises the possibility that
inappropriately expressed cellular dsRNA-binding proteins could
activate TLR3 signaling from cellular RNAs. Autoimmunity has
been linked to antibodies that recognize RNP complexes [63,64],
and TLR signaling can affect the production of autoantibodies
associated with lupus erythematosis [65].
The HCV polymerases
The results in this work are also informative for the function of
the HCV polymerase. We note that the enhancement of TLR3
signaling by HCV polymerase is independent of RNA synthesis
since the active site mutant is capable of enhancing TLR3
signaling (Fig. 3D). All polymerases undergo structural transitions
between open and closed conformations in response to the stages
of nucleic acid synthesis. Indeed, the monomer of the HCV
polymerase contains a template channel that can sterically
accommodate ssRNA, but not dsRNA [26,66]. During the
formation of a nascent RNA from the template, however, the
polymerase needs to release the interaction between the D1 loop
and the thumb subdomain in order to accommodate the
elongating nascent RNA-template RNA duplex. The 1bD21 can
both extend from a primed template as well as initiate from the 39
terminus of a single-stranded RNA. We believe that this is a
manifestation of the 1b polymerase existing in an equilibrium
between the open and closed forms in vitro, likely accounting for
better dsRNA-binding by the 1b polymerase and its enhanced
ability for dsRNA-induced signaling by TLR3. In contrast, the 2a
polymerase exists predominantly in a closed conformation and
thus is less able to bind to dsRNA and enhance signaling by TLR3
[29]. Increasingly, the open and closed conformations of the HCV
polymerases are being linked to polymerase function. For the 1b
HCV polymerase, the open conformation also exposes a binding
pocket for the cell cycle regulator retinoblastoma and mediates the
ubiquitinylation and degradation of retinoblastoma to increase cell
cycle progression during HCV infection [67,68].
During viral infection, viral polymerases and RNAs are
expressed inside the cell and depending on the cellular locations
of the polymerase protein and viral or cellular dsRNAs they
recognize, could activate cytoplasmic innate immunity receptors
such as RIG-I or endosomal TLRs. Previous study by Naka et al
[69] found that immortalized liver cells stably transfected with
HCV NS5B and HEK 293 cells stably transfected with both NS5B
and TLR3 genes show increased activation of TLR3-depedent
IFNb signaling, although the activation in HEK 293 cells was only
2-fold. In a recent study from our laboratory, transient
overexpression of NS5B and RIG-I resulted in 8 to 14-fold
induction of IFNb promoter-driven luciferase activity in Huh7 and
in HEK 293T cells while overexpression of NS5B and TLR3 had
no effect, suggesting that expression of NS5B in these two cell lines
predominantly activates cytoplasmic innate immunity receptors
such as RIG-I and MDA5 [70]. In both these studies, the NS5B
polymerase was expressed from transfected plasmids and catalytic
activity of the polymerase is required. In the present study,
exogenously added HCV polymerase protein activates TLR3
without requiring RNA synthesis since polymerase mutated at the
catalytic site still activates TLR3. In addition three viral capsid
proteins as well as LL37 that bind RNA but do not have catalytic
activity also activate TLR3 signaling. Addition of both dsRNA and
the RNA-binding protein are required for this activation. RNA-
binding protein alone has no effect since RNAs synthesized by the
HCV polymerase in cells may not enter efficiently into acidic
endosomes, the site of TLR3 signaling [15]. Thus the effect and
mechanism of TLR3 activation by RNA-binding protein are likely
different from that observed by Naka et al. [69] or Ranjith-Kumar
et al. [70].
During viral infection and subsequent cell lysis, viral proteins
and RNAs may be released to the cell media and these viral
proteins and RNAs may be taken up by cells to activate innate
immunity. Exogenously added HCV core and NS3 proteins enters
cells to activate TLR2 signaling in the absence of any added
ligand, although the mechanism(s) of activation is not known [71].
In the present study, addition of NS5B protein to BEAS2B or
HEK293T cells has minimal effect on its own but significantly
activates TLR3 signaling in combination with dsRNA ligands,
including viral dsRNAs (Table S1). Indeed, NS5B and the RRV
capsid protein have the ability to enters BEAS-2B cells within
30 min and colocalize with endosomal TLR3 by 6 h. The cellular
entry of released viral proteins and RNAs during viral infection
may contribute to the cellular innate immune responses and could
provide a point for therapeutic intervention.
Materials and Methods
Reagents
Recombinant genotype 1b (Con1 strain) and 2a (JFH-1) HCV
polymerases lacking the C-terminal transmembrane helix were
purified from E. coli as described by Chinnaswamy et al. [28]. The
preparations were devoid of detectable contaminating RNA,
DNA, or LPS. The HBV and RRV capsid proteins were expressed
in E. coli and purified according to Porterfield et al. [38] and
Mukhopadhyay et al., [39]. Poly(I:C) was purchased from
Amersham Biosciences (Piscataway, NJ) and reconstituted in
phosphate-buffered saline. RNA from purified Reovirus virions
was extracted with Trizol, followed by ethanol precipitation and a
wash with 70% ethanol. The purified RNA was stored in RNase-
free water. S4 dsRNA from Reovirus was synthesized by in vitro
transcription from cDNA (kind gift of P. Danthi, Indiana
University, Indiana) that has been engineered to have T7
promoters at termini of the two complementary strands. The
annealed RNAs were then analyzed for quantity and concentra-
tion before use. BPEV dsRNA was purified according to the
protocol of Valverde and Gutierrez [43] and stored in RNase-free
water. BEAS2B and HEK293T cells were from ATCC and
cultured in BEGM media with supplements (Lonza, Basel,
Switzerland).
Quantification of IL6 level in culture supernatant
Culture media from BEAS-2B cells were collected 24 h after
treatments, centrifuged at 2000 g for 2 min, and the supernatants
were assayed for IL6 secretion using a human IL6 ELISA kit along
with quantification controls (BD systems) as per the manufacturer’s
protocol.
TLR3 luciferase reporter assay
HEK293T cells were plated in CoStar white 96-well plates in
DMEM amended with 10% FBS at 4.4610
4 cells per well and
transfected at ,85 to 90% confluency with a mixture of the
Lipofectamine 2000 and plasmids pISRE-Luc, pUNO-huTLR3
and phRL-TK as described in Sun et al. [44]. The transfected cells
were induced 18 to 22 h later by the addition of poly(I:C) or viral
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mL in the presence or absence of 100 nM of RNA binding
proteins. The cells were harvested for analysis of luciferase 14 to
18 h after poly(I:C) addition.
RdRp assays
RdRp assays were performed as 20 mL reactions containing
20 mM sodium glutamate (pH 8.2), 12.5 mM DTT, 4 mM
MgCl2, 1 mM MnCl2, 0.5% Triton X-100, 0.2 mM GTP,
0.1 mM ATP and UTP, 250 nM [a-
32P] CTP (MP Biomedicals),
2 pmol PE46 and 1 pmol LE19p as templates [26]. The reaction
mixture was incubated at 30uC for 1 h and terminated by phenol-
chloroform extraction, followed by precipitation of the RNA in the
presence of two volumes of ethanol, 5 mg glycogen and 0.3 M
NaOAc (pH 5.2). RNA products were separated by 20%-7.5 M
urea polyacrylamide gels. The signals were detected and
quantified by using a PhosphorImager.
UV cross-linking assay and gel shift assay
Each reaction contained 400 ng of purified protein mixed with
1 pmol Cy5-labeled SL26 or S4 dsRNA radiolabled by a
polynucleotide kinase reaction in a buffer containing 50 mM
Tris-HCl (pH 7.5), 4 mM MgCl2, 50 mM NaCl, and 1 mM
dithiothreitol. The reaction was irradiated with UV at 1200 mJ for
3 min. and then subjected to SDS-PAGE. The signals were
detected and quantified with a phosphorimager. The gel was then
stained with Coomassie blue to visualize the locations of proteins.
Differential scanning fluorimetry
DSF was performed in a Stratagene MX3005P Real-time PCR
machine according to the protocol of Niesen et al. [72]. Each
sample (5 mM final concentration) was prepared in a total volume
of 50 mL containing SYPRO orange (Molecular Probes) in
100 mM Tris, pH 7.0, 50 mM KCl, and 5 mM MgCl2). The
ramp condition was from 25 to 75uC, at increments of 0.5uC/min
and the change in fluorescence intensity used to determine the Tm
values with the use of KaleidaGraph Software (Synergy, Reading,
PA).
siRNA knockdown experiments
BEAS-2B cells were seeded at 1.0610
5 cells/well in BEGM
amended with supplements (Lonza, Switzerland) in a 48-well tissue
culture plate or 1.0610
4 cells/well in a 96-well plate. 6 h later, the
cells were transfected with a pool of three siRNAs specific to
TLR3, nonspecific control siRNA (Santa Cruz Biotechnology
Inc.), or siRNA to RIG-I (Qiagen, Valencia CA). 30 nM SiRNAs
were transfected using Lipofectamine RNAiMax (Invitrogen,
Carlsbad CA) according to the manufacturer’s protocol. The cells
were incubated for 48 h prior to treatment with ligands and
proteins. Culture media was collected 24 h later and assayed for
IL6 production using ELISA. RT-PCR analysis of the TLR3
mRNA to confirm the effects of the siRNA knockdown was
performed. After treatments total RNA samples pooled from
either six wells of a 96-well plate or three wells of a 48-well plate
were isolated from BEAS2B cells using RNeasy kit (Qiagen,
Valencia, CA). 0.5 mg of total RNA was then reverse transcribed to
cDNA with MMLV reverse transcriptase (Ambion, Austin, TX)
using random decamers (New England Biolabs, Ipswich, MA).
cDNA generated from 16 ng of total RNA was amplified using
SYBR Green Supermix (Bio-Rad, Hercules, CA) with an initial
3 min denaturing temperature of 95uC, followed by a total of 40
cycles of 30 s of denaturation at 95uC and 30 s of annealing at
55uC and elongation at 72uC. TLR3-specific primers were
previously used by Homma et al. [73]: (forward: 59-GATCT-
GTCTCATAATGGCTTG-39; reverse: 59-GACAGATTCC-
GAATGCTTGTG-39; and GAPDH primers (59-GAGTCAACG-
GATTTGGTCGT-39; reverse: 59-TGGGATTTCCATTGAT-
GACA-39) were used. For each sample, TLR3 Ct values were
subtracted from corresponding GAPDH Ct values. TLR3 mRNA
levels for each treatment were calculated as %TLR3 mRNA for
samples treated with control nonspecific siRNA.
Fluorescence microscopy
BEAS-2B cells were seeded on coverslips in 6 well plates. Highly
purified recombinant NS5B (0.2 mM) that was free of pyrogen was
added to the cells at the same time as the dsRNAs and incubated
for 30 min at 37uC. After washing with PBS, cells were fixed with
4% paraformaldehyde at room temperature for 30 min. After two
additional washes with PBS, they were permeabilized with 0.5%
Triton X-100 at room temperature for 10 min. The cells were
then washed twice more with PBS amended with 0.02% Tween-
20 (TBS-T) and incubated with blocking buffer (1% BSA in PBS)
for 1 h at room temperature. After washing three times with PBS-
T, slides were incubated with anti-NS5b antibody (mAb; 5B-3B1
from Alexis Biochemicals) and goat anti-TLR3 (R&D systems,
Minneapolis, MN) overnight at 4uC. Slides were then probed with
a Texas Red-labeled bovine anti-goat mAb (Santa Cruz
biotechnology) for 1 h at RT, washed, then incubated with a
goat anti-mouse secondary antibody conjugated with Alexa fluor
488 (Santa Cruz Biotechnology) for 1 h at room temperature.
Coverslips were washed with PBS-T three times, air dried for 1 h
and mounted in Vectashield mounting medium with DAPI
(Vector Laboratories). The images were obtained on a Leica
TCS SP5 scanning confocal microscope with an HCX PL APO
Lambda Blue 63 X 1.4 oil objective lens (Leica Microsystems).
Excitation was at 20% of the maximum laser power. Images were
captured with a scanning speed of 200 Hz and image resolution of
5126512 pixels and then analyzed using Leica Application Suite
2.02.
Ross River virus capsid protein (0.2 mM) was added the culture
media of BEAS-2B cells seeded on coverslips for up to 6 hours at
37uC. The cells were washed and fixed as described above. The
cells were incubated with anti R-cp rabbit polyclonal antibody
(custom prepared by Cocalico Biologicals, Reamstown, PA) and
anti-TLR3 (mAb, a kind gift of L. San Mateo of Centocor Inc)
diluted in PBS+0.1% BSA+0.01% TX100 overnight at 4uC. Slides
were then probed with a goat anti-mouse secondary antibody
conjugated with Alexa fluor 488 (Santa Cruz Biotechnology) for
TLR3 and bovine anti-rabbit Texas Red (Santa Cruz Biotech-
nology) for R-cp for 1.5 h at room temperature. The slides were
imaged and the results analyzed as described above.
Supporting Information
Figure S1 Effects of various RNAs on IL6 production. A)
Results from BEAS-2B cells. The endornaviral dsRNAs labeled
A–C were extracted from several rice isolates collected in Lousiana
and have distinct migrations in agarose gels. However, the
genomes have not been determined. pIC, pAU, and pGU are
three homopolymeric RNAs. The single-stranded viral RNAs were
all extracted from purified virions. All RNAs used were at a final
concentration of 0.5 mg/ml. B) A time course of IL6 production by
BEAS-2B cells in response to poly(I:C) and S4 dsRNA. The
addition of LL37 to 3 mM final concentration resulted in TLR3
enhancing signaling in response to the S4 dsRNA or poly(I:C). C)
Results from HEK 293T cells expressing recombinant TLR3. All
RNAs were used at 1 mg/ml. The ratios denote the ratio of the
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the same cells.
(TIF)
Figure S2 Additional characterization of the 1b HCV
polymerase that could affect IL6 production in BEAS-2B
cells. A) Effects of poly(I:C) of different lengths on IL-6
production. The poly(I:C) fragments were separated on a
denaturing gel and eluted from the gel fragments. The eluted
fragments were annealed and their lengths determined by
comparison to an DNA ladder. B) Effects of several recombinant
HCV polymerase proteins on TLR3 induction of IL6. The final
concentrations of the proteins added are shown on the horizontal
axis. The amount of poly(I:C) in each reaction was at 0.13 mg/ml.
C) A demonstration that the mutant HCV polymerases retain the
ability to bind the SL26 RNA.
(TIF)
Figure S3 Macropinocytosis may be involved in TLR3
signaling. A) Effects of 5-(N-ethyl-N-isopropyl)-amiloride (aka
EIPA) on TLR3 signaling. Where present, LL37 was at the final
concentrations of 3 mM, 1bD21 or 2aD21 were at 0.5 mM, and
poly(I:C) was at 0.13 mg/ml. B) Concentration-dependent inhibi-
tion of signaling by TLR3 in the presence of poly(I:C) and the
cofactors.
(TIF)
Figure S4 Additional information on viral capsids and
their effect on TLR3 signaling. A) The sequence of the
hepatitis B virus capsid protein. The residues present in H-cp183
but absent in H-cp149 are underlined and the arginine residues
are in blue. B) Concentration-dependent effects of the viral capsid
proteins on TLR3 signaling. C) A demonstration that the capsids
from BMV and RRV that have ssRNA genomes can bind the S4
dsRNA. The gel is from a nondenaturing stacked polyacrylamide
gel of 5 and 20%. The S4 dsRNA was radiolabeled during in vitro
transcription of the plus- and minus-strands and then annealed at
a 1:1 ratio.
(TIF)
Figure S5 Localization of the R-cp in BEAS-2B cells 2 h
after addition into the cell culture medium. R-cp is stained
red. The boxed area in the upper right is enlarged to show that
small punctate spots of R-cp can be found in the cell’s cytoplasm.
(TIF)
Table S1 Effects of RNA-binding proteins on IL6 levels
in BEAS-2B cells.
(TIF)
Table S2 Effects of siRNAs to TLR3 on TLR3 mRNA
levels in BEAS-2B cells, as determined by RT-PCR.
(TIF)
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